The Enterprise Value as of November 2024 (TTM) for Nuvectis Pharma, Inc. (NVCT) is 100.52M

According to Nuvectis Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 100.52M. This represents a change of -21.14% compared to the average of 127.46M of the last 4 quarters.

Nuvectis Pharma, Inc. (NVCT) Historical Enterprise Value (quarterly & annually)

How has NVCT Enterprise Value performed in the past?

The mean historical Enterprise Value of Nuvectis Pharma, Inc. over the last ten years is 65.62M. The current 100.52M Enterprise Value has changed 15.22% with respect to the historical average. Over the past ten years (40 quarters), NVCT's Enterprise Value was at its highest in in the June 2023 quarter at 217.79M. The Enterprise Value was at its lowest in in the September 2021 quarter at 31.60M.

Nuvectis Pharma, Inc. (NVCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nuvectis Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nuvectis Pharma, Inc. (NVCT) Average Enterprise Value

How has NVCT Enterprise Value performed in the past?

The current Enterprise Value of Nuvectis Pharma, Inc. (NVCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nuvectis Pharma, Inc. (NVCT) Enterprise Value vs. Peers

How is NVCT’s Enterprise Value compared to its peers?

Nuvectis Pharma, Inc.’s Enterprise Value is less than Replimune Group, Inc. (748.93M), greater than Lyra Therapeutics, Inc. (21.80M), greater than Kronos Bio, Inc. (12.41M), less than Gossamer Bio, Inc. (312.60M), less than Olema Pharmaceuticals, Inc. (672.27M), less than Larimar Therapeutics, Inc. (453.95M), less than Centessa Pharmaceuticals plc (1.75B), less than Orchestra BioMed Holdings, Inc. (181.24M), less than Monte Rosa Therapeutics, Inc. (481.11M), less than NewAmsterdam Pharma Company N.V. (1.09B), less than Inventiva S.A. (230.21M), less than Cullinan Oncology, Inc. (811.28M), less than Compass Therapeutics, Inc. (211.64M), greater than Ikena Oncology, Inc. (47.35M), greater than Aerovate Therapeutics, Inc. (48.42M), less than Eliem Therapeutics, Inc. (119.64M), greater than Decibel Therapeutics, Inc. (96.42M), greater than Anebulo Pharmaceuticals, Inc. (45.92M), greater than Werewolf Therapeutics, Inc. (1.89M), less than Edgewise Therapeutics, Inc. (3.20B), less than Celcuity Inc. (640.39M), less than C4 Therapeutics, Inc. (462.04M),

Build a custom stock screener for Nuvectis Pharma, Inc. (NVCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvectis Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuvectis Pharma, Inc. (NVCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuvectis Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.